A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
St. Jude Children's Research Hospital
Labcorp Corporation of America Holdings, Inc
Children's National Research Institute
Cardinal Health 414, LLC
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Celgene
European Organisation for Research and Treatment of Cancer - EORTC